EXTENDED EARLY BIRD RATE until 11th September 2023

BOPA Symposium Wales 2023: EARLY BIRD RATE extended until 11th September 2023

 

Oncology and haematology are ever-changing landscapes and this year we are looking to the future. The conference will include an exciting variety of specialist panel discussions, core clinical updates and specific research-focused streams. We are running a tiered system with sessions for everyone; from new to oncology pharmacists to advanced practitioners.

We recognise that NHS budgets are tighter than ever, so the committee have worked hard to give BOPA members a reduced conference fee of £260 (including VAT) if booked by the 11th September. As usual we have preferential rates at hotels nearby, but there are plenty of other options if you want to independently find accommodation.

To register, please CLICK HERE. Only PAID members will have access. For non-members link please contact [email protected]

For more information please click: https://www.bopa.org.uk/latest-symposium-2023/
For the draft agenda please click here

We look forward to seeing you all in Wales. Keep an eye out for monthly updates.

BOPA Symposium committee with Media1 Productions 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article